-
Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland.
-
Publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the life sciences sector. (OTCBB:AGNM)
-
Develops and commercializes innovative small molecule drugs, initially for improving cancer treatments. Based in Westminster, Colorado. (Nasdaq: ALTH)
-
Develops compounds for the diagnosis of viral and non-viral induced tumour-related diseases in Innsbruck, Austria.
-
Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada.
-
Develops organic chemistry and immunotherapy technology to produce synthetic therapeutic vaccines targeting proliferative tumors. Resources for patients and professionals and investors, with profile of company based in Edmonton, Alberta. (Nasdaq: BIOM)
-
Biotechnology research company offering products for diagnosis, imaging and treatment of cancers, including drugs in pre-clinical development. Lists technology, patents, corporate overview and contacts.
-
Company focused on the discovery and development of anti-cancer drugs through synthetic biology of natural polyketides and rapamycin analogues. Describes technology, pipeline, and facilities near Saffron Walden, England.
-
Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. (Nasdaq: BLSI).
-
Introduction the mechanisms, with resources in oncology, vascular medicine and immunolgical disease, including possible therapies and links to related organizations, presented by Genentech, Inc.
-
Developing tumor-derived activated cell technology for therapy and vaccines. Overview of principles and contacts in Thomasville Georgia, USA.
-
Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK.
-
Preclinical-stage biopharmaceutical company that designs, develops and commercializes technologies for cancer metastasis research and treatment. Worldwide news, products and contacts in Bizkaia, Spain.
-
Focusing on the development of delivery systems to target solid tumors, such as prostate with nanoencapsulated biotherapeutics. Includes brief overview of concepts from Chaska, Minnesota.
-
Resource treatments aimed at chronic management, focusing on anti-angiogenesis, apoptosis, B-cell biology and HER signaling. Includes sections for professionals, customers and patients, with contacts in South San Francisco, California.
-
Offers products in angiogenesis and cell growth regulation, focusing on protected ligands that target specifically to sarcomas and melanomas. Includes research and technology overview, and information for investors in Helsinki, Finland.
-
Development and commercialization of vaccines, and treatments, such as telomere homologs and angiogenesis inhibition. Includes product pipeline, clinical trials, corporate profile and contacts in Carlsbad, California.
-
A biomolecular diagnostics company engaged in the design, development and commercialization of cancer screening systems. Investor, products, services, locations, technologies, careers are discussed.
-
Diagnostic and therapeutic products relating to prostate specific antigen and oncoproteins, within a division of Bayer in Cambridge, Massachusetts
-
Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK.
-
Biotechnolgy company developing gene therapy system, using a bacterial enzyme, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts.
-
Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California.
-
Developing stem cell products and therapies for hepatic diseases, offering human hepatocytes and microsomes for pre-clinical research. Overview of services, references, related links and contacts in Pathumthani, Thailand.
-
Develops, produces, and licenses proprietary therapies for the treatment of cancer. Includes introduction to targeted oncology, investment data, and profile of company.
-
Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England.
|
|
